Loading...

Novo Nordisk A/S

NONOF•PNK
Healthcare
Biotechnology
$40.32
$-1.18(-2.84%)
U.S. Market opens in 2h 8m

Novo Nordisk A/S (NONOF) Stock Overview

Explore Novo Nordisk A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap178.5B
P/E Ratio10.97
EPS (TTM)$3.61
ROE0.61%
Fundamental Analysis

AI Price Forecasts

1 Month$33.28
3 Months$55.77
1 Year Target$0.00

NONOF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novo Nordisk A/S (NONOF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.97 and a market capitalization of 178.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.84%
5-Day Change
-0.71%
1-Month Change
14.25%
3-Month Change
-32.81%
6-Month Change
-22.96%
Year-to-Date (YTD) Change
-21.02%
1-Year Change
-39.82%
3-Year Change
-51.57%
5-Year Change
7.95%
All-Time (Max) Change
140.43%

Contact Information

https://www.novonordisk.com
45 44 44 88 88
Novo Allé 1, Bagsvaerd, NaN, 2880

Company Facts

77,406 Employees
IPO DateMay 7, 2010
CountryDK
Actively Trading

Frequently Asked Questions